Galil Medical Merging with Endocare
Endocare Inc. (Nasdaq: ENDO) has agreed to merge with Galil Medical Ltd., an Israel-based maker of cryotherapy systems for use in kidney and prostate cancer treatments. Under terms of the arrangement, Endocare stockholders will hold 52% of the combined company, while Galil shareholders will hold the remaining 48 percent. Galil Medical has raised over $40 million in VC funding from firms like Thomas, McNerney & Partners, The Vertical Group and Elron Electronic Industries Ltd.
11 November 2008•4 mins read
